Small molecules and targeted therapies in distant metastatic disease

Chemotherapy, biological agents or combinations of both have had little impact on survival of patients with metastatic melanoma. Advances in understanding the genetic changes associated with the development of melanoma resulted in availability of promising new agents that inhibit specific proteins u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hersey, P., Bastholt, L., Chiarion-Sileni, V., Cinat, G., Dummer, R., Eggermont, A. M. M., Espinosa, E., Hauschild, A., Quirt, I., Robert, C., Schadendorf, D.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712592/
https://www.ncbi.nlm.nih.gov/pubmed/19617296
http://dx.doi.org/10.1093/annonc/mdp254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712592/
https://www.ncbi.nlm.nih.gov/pubmed/19617296
http://dx.doi.org/10.1093/annonc/mdp254

Ejemplares similares